These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9140926)

  • 1. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
    Schneider P; Korolenko TA; Busch U
    Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterophagic function and rate of intralysosomal proteolysis during lysosomotropic agents administration.
    Korolenko TA; Pupyshev AB; Malygin AE
    Acta Biol Med Ger; 1981; 40(10-11):1613-7. PubMed ID: 7342605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of intralysosomal protein catabolism using lysosomotropic agents--proteolysis and protease inhibitors].
    Korolenko TA; Pupyshev AB; Mudrakovskaia AV
    Vopr Med Khim; 1987; 33(5):93-6. PubMed ID: 3686902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of single and repeated administration of chloroquine on the activity of lysosomal proteinases in rat liver cells].
    Korolenko TA; Rukavishnikova EV; Pupyshev AB
    Vopr Med Khim; 1990; 36(6):20-3. PubMed ID: 2075715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic measurements of the acute and chronic effects of lysosomotropic agents on hepatocyte lysosomal pH using flow cytometry.
    Myers BM; Tietz PS; Tarara JE; LaRusso NF
    Hepatology; 1995 Nov; 22(5):1519-26. PubMed ID: 7590671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
    Pisonero-Vaquero S; Medina DL
    Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased degradation in rat liver induced by vinblastine. I. Biochemical characterization.
    Marzella L; Glaumann H
    Lab Invest; 1980 Jan; 42(1):8-17. PubMed ID: 7351833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy metals and lysosomes.
    Sternlieb I; Goldfischer S
    Front Biol; 1976; 45():185-200. PubMed ID: 789127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the lysosomotropic preparation suramin on the ultrastructural and functional characteristics of rat liver cells in acute toxic hepatitis].
    Vakulin GM; Korolenko TA; Pupyshev AB; Malygin AE; Kurysheva NG
    Tsitologiia; 1986 Aug; 28(8):854-61. PubMed ID: 3775856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lysosomes and apoptosis].
    Vikić-Topić D; Carević O
    Acta Med Croatica; 2009 Oct; 63 Suppl 2():21-5. PubMed ID: 19999542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lysosomotropic agents as regulators of the activity of lysosomal hydrolases].
    Bulychev AG; Assinovskaia OA; Semenova EG
    Vopr Med Khim; 1987; 33(5):20-4. PubMed ID: 3686895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review).
    Agostinelli E; Seiler N
    Int J Oncol; 2007 Sep; 31(3):473-84. PubMed ID: 17671672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomotropic agents induce morphological and functional changes in human muscle cells in vitro.
    Baron PL; Meola G; Scarpini E; Moggio M; Santilli I; Scarlato G
    Eur J Basic Appl Histochem; 1991; 35(4):423-32. PubMed ID: 1801935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic vacuolization during exposure to drugs and other substances.
    Aki T; Nara A; Uemura K
    Cell Biol Toxicol; 2012 Jun; 28(3):125-31. PubMed ID: 22431173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high content screening assay for identifying lysosomotropic compounds.
    Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
    Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents.
    Kwok JC; Richardson DR
    Mol Pharmacol; 2004 Jan; 65(1):181-95. PubMed ID: 14722250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective autophagy of clofibrate-induced rat liver peroxisomes. Cytochemistry and immunocytochemistry on tissue specimens and on fractions obtained by Nycodenz density gradient centrifugation.
    Nardacci R; Sartori C; Stefanini S
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1277-90. PubMed ID: 11075957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
    Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of intact lysosomes from human RPE cells and effects of A2-E on the integrity of the lysosomal and other cellular membranes.
    Schütt F; Bergmann M; Holz FG; Kopitz J
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):983-8. PubMed ID: 12483320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Facilitation of the structural and functional disorders of liver lysosomes in toxic hepatitis due to the suppression of intralysosomal proteolysis].
    Korolenko TA; Pupyshev AB; Malygin AE; Gavrilova NI; Kurysheva NG
    Biull Eksp Biol Med; 1985 Aug; 100(8):169-72. PubMed ID: 3896340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.